UnitedHealth Group Incorporated
UNH - NYSE - $368.78 ▼ -%0.46
-
Earnings Tue 4 Aug

UnitedHealth opens the
books on Tuesday evening.

2 analysts' median target is $380[FMP target], stock is $369, +3.0% upside potential. After Q1 +9.9% EPS beat[FMP earnings], the stock moved +2.2%.

summary below
Quick Take - in 40 seconds
B+
HOLD Council 3/6 - Moonshot 40

B+ = MoonshotScore 40[9-pillar formula] + Council 3/6[6-lens rule]. Form 4: 0 transactions[FMP Form 4].

Q1 consensus: revenue $110.7B[FMP est], EPS $4.83[FMP est]. 3 consecutive quarters of beat[FMP earnings].

$4.83 EPS Estimate Last year $7.23 - +18% YoY YoY
3 Beat Streak Expectations beaten consecutively for the last 3 quarters

Q1 EPS +9.9% beat[FMP] but the stock +2.2% D+1[FMP D+1]. Wayne DeVeydt promised $763.0M CapEx + a sequential decline in Q1 during the Q1 earnings call[Wayne DeVeydt capex transcript].

Watchlist

6 metrics stand out this quarter.

3 Risk Indicator

Optum Health Margin Improvement

optum_health_margin_improvement

Optum Health is focused on steadily improving margins for 2026 and accelerating into 2027.

"As we have shared over the past 3 quarters, our efforts are focused on management and process improvements that steadily improve margins at Optum Health for 2026 and accelerate into 2027."

- Patrick Conway - Q1 FY26 Earnings Call - April 21, 2026
2026 Expectation / Guide

Medicaid Margin Outlook

medicaid_margin_outlook

UnitedHealthcare expects membership attrition and negative margins in Medicaid in 2026 due to continuing high trend and insufficient funding, with modest margin improvements beginning in 2027.

"We continue to expect membership attrition and negative margins in 2026 in light of continuing high trend and insufficient funding with modest margin improvements beginning in 2027."

- Timothy Noel - Q1 FY26 Earnings Call - April 21, 2026
2026 Risk Indicator

Margin Recovery Focus

margin_recovery_focus

UnitedHealthcare is prioritizing margin recovery and product stability in 2026, with a deliberate trade-off on membership growth, particularly in Medicare and commercial markets.

"Our 2026 approach prioritizes margin recovery and product stability with a deliberate trade-off on membership growth, particularly in Medicare and commercial markets."

- Timothy Noel - Q1 FY26 Earnings Call - April 21, 2026
76% Investor Focus

Ai Driven Efficiency Optum Insight

ai_driven_efficiency_optum_insight

Optum Insight's new AI-first products continue to gain traction, with Optum Real helping payers and care providers deal more efficiently with administrative functions such as claim adjudication and coverage validation and can reduce manual contact costs by 76%.

"Optum Real is helping payers and care providers deal more efficiently with administrative functions such as claim adjudication and coverage validation and can reduce manual contact costs by 76%."

- Patrick Conway - Q1 FY26 Earnings Call - April 21, 2026
50% Investor Focus

Prior Authorization Improvements

prior_authorization_improvements

UnitedHealthcare is working to improve prior authorization processes, with about 50% of requests now processed in real time, and more than 90% approved on average in 1 business day.

"About 50% of those are processed in real time, and more than 90% are approved on average in 1 business day."

- Timothy Noel - Q1 FY26 Earnings Call - April 21, 2026
1/3 Investor Focus

Aca Membership Decline

aca_membership_decline

UnitedHealthcare still expects total membership to decline by approximately 1/3 in 2026.

"We still expect total membership to decline by approximately 1/3 in 2026."

- Timothy Noel - Q1 FY26 Earnings Call - April 21, 2026

Stock Expert AI - Methodology

Do our 9 pillars, 7 perspectives, and Munger lens point in the same direction?

Council Score 3 / 6 Bullish

6 investor frameworks. 3 bullish (Ray Dalio, Ken Griffin, Buffett), 1 bearish (Jim Simons), 2 neutral (Klarman, Munger).

How is it calculated? ->
Ray Dalio macro - target upside +3.0%
Ken Griffin flow - 50d MA above
Jim Simons quant - RSI 83
Klarman value - target upside +3.0%
Buffett quality - ROE score 4/5
Munger valuation - target upside +3.0%
Munger's Mindset character & balance sheet lens
Fairly Valued

Quality business, trading at fair value.

How is it calculated? ->
Financial HealthModerate
Margin of SafetyWeak
Interest CoverageAdequate
ROIC vs WACCHealthy
Technical Levels - Pre-earnings positioning

What levels is the stock being tested at?

RSI(14)
82.7 RSI 82.7 overbought, 50d above
MACD
+22.40 price above 50d - support positive
50d MA
$301 stock 22.4% above - short-term support
200d MA
$315 stock 16.9% above - long-term support
Volume (10d)
-51% decrease - low participation
Resistance
$380
Analyst median target - upgrade trigger if broken
Current
$369
Pre-earnings position
Support
$268
Invalidation - close below this is a technical breakdown
Pattern
Range
$268-$380 band - earnings breakout/breakdown trigger

Past Performance

UnitedHealth's last 8 quarters: 3 consecutive beats.

MISS
Q2 FY25
$4.08 vs $4.45 est - +1.9%
BEAT
Q3 FY25
$2.92 vs $2.80 est - -3.4%
BEAT
Q4 FY25
$2.11 vs $2.10 est - +4.0%
BEAT
Q1 FY26
$7.23 vs $6.58 est - +2.2%

Q1 (April 21, 2026): EPS $7.23 vs $6.58 est[FMP], +9.9% beat. D+1 movement: +2.2%[FMP D+1]. Decline despite beat - market reacted to guidance, not numbers.

Three scenarios: what could happen?

EPS < $4.69 (no guidance)

Q1: EPS $7.23 vs $6.58 beat[FMP], stock +2.2% D+1[FMP].

Backlog concentration

No RPO/backlog concentration disclosed in Q1 earnings call.

CapEx shock

Q1 CapEx $763.0M[FMP cashflow]. Q1 op margin 8.0%[FMP op margin] - this level in Q1 is sensitive to CapEx revision risk.

Framework - Position discipline

After the data arrives: 3 scenarios, 3 windows

Not advice - a structural framework for earnings night. Decision discipline is yours.

Scenario A - Beat
Q1 EPS > $4.83 + CapEx discipline
Threshold: EPS > $4.83[FMP est].
Target: Break above median target $380[FMP target]; high target $444[FMP] upper bound.
Scenario B - In-Line
EPS approx $4.83 + CapEx < $763.0M
Threshold: EPS approx $4.83[FMP est], Q1 CapEx < $763.0M[FMP].
Target: Consolidation in the band between current $369[FMP] and median $380[FMP].
Scenario C - Miss
EPS < $4.69 or CapEx >= $763.0M
Threshold: EPS < $4.69[FMP estx0.97].
Target: Current $369 below SMA200 $315[FMP], if rejection continues, $268[derived] support activates.
Sizing
Earnings volatility -> max portfolio 1-2%. Waiting for earnings is not a gamble, it's a position entrustment.
Timing
IV crush within 24 hours post-earnings. Waiting for premium decay makes options preferable to spot.
Staging
Don't go all-in at once, divide into 3: initial reaction, 24 hours later, after Friday's close.

Market Outlook

What do 2 analysts say?

Wall Street Consensus
$380
12-month median target price (+3.0% upside potential)
23
BUY
4
HOLD
1
SELL
Risk Management
$268
Invalidation level - critical support threshold
$301 - 50-day MA (above, +22.4%)
$315 - 200-day MA (above, +16.9%)
IV Crush risk (sudden drop in inflated option premiums before earnings): Option premiums are inflated before earnings.
Verdict - UNH Q1 FY27
B+

You read it in 5 minutes. When the numbers come out on Tuesday evening - you know what you're looking at.

Data arrives at night. The framework is ready now.

Data arrives on Tuesday evening. The framework is ready on this page: Q1 EPS threshold $4.83[FMP], CapEx threshold "below $763.0M"[Wayne DeVeydt]. Two anchors, three scenarios.

Comparison Stock Expert AI Pro $24/month ($240/year), 77% cheaper than the total of three earnings-tracking tools ($1,059/year -> $240/year).

3 subscriptions. 1 platform.

Seeking Alpha $299/yr - analyst opinions + earnings coverage TipRanks $360/yr - Smart Score (1-10) + analyst consensus + insider trades Trendspider $400/yr - AI pattern detection + automated TA + multi-timeframe alerts

Prices as of April 2026. Sources: seekingalpha.com/subscriptions - tipranks.com/pricing - trendspider.com/pricing

Stock Expert AI Pro: $24/month ($240/year). Council 7-lens analysis + MoonshotScore 9-pillar + Insider tracker + Technical levels - all in one platform, for every stock.

Educational tool, not investment advice. Past performance does not guarantee future results.

Calendar

Catalyst Calendar - 90-day forward look

Aug 4, 2026EARNINGSQ1 FY27 results (after market close) + earnings call
Aug 5, 2026PRICEFirst trading day after earnings - 200dMA test + IV crush
Sep 18, 2026FILING10-Q deadline - segment breakdown + RPO detail (SEC rule: quarter-end + 45 days)
~Nov 4, 2026EARNINGSQ2 FY27 (next quarter, date not yet scheduled in FMP)

DATA GAP: Events not in the FMP /stable/calendar feed - Investor day, analyst day, product launches, regulatory dates. These require company IR page scraping or manual calendar entry.

Frequently Asked Questions

What does the UNH earnings preview cover?

This UNH (UNH) earnings preview covers the analyst consensus, key catalysts, and what to watch on the earnings call.

What should investors watch for in UNH earnings?

Consensus EPS, revenue guidance, segment growth rates, and the tone of management commentary — the full breakdown with sources is on this page.